Reaction Details Report a problem with these data
Target
Placenta growth factor
Ligand
BDBM50339227
Substrate
n/a
Meas. Tech.
ChEMBL_736105 (CHEMBL1692888)
IC50
>10000000±n/a nM
Citation
 Bower, KE; Lam, SN; Oates, BD; Del Rosario, JR; Corner, E; Osothprarop, TF; Kinhikar, AG; Hoye, JA; Preston, RR; Murphy, RE; Campbell, LA; Huang, H; Jimenez, J; Cao, X; Chen, G; Ainekulu, ZW; Datt, AB; Levin, NJ; Doppalapudi, VR; Pirie-Shepherd, SR; Bradshaw, C; Woodnutt, G; Lappe, RW Evolution of potent and stable placental-growth-factor-1-targeting CovX-bodies from phage display peptide discovery. J Med Chem 54:1256-65 (2011) [PubMed]  Article 
Target
Name:
Placenta growth factor
Synonyms:
PGF | PGFL | PLGF | PLGF_HUMAN
Type:
PROTEIN
Mol. Mass.:
24794.98
Organism:
Homo sapiens (Human)
Description:
ChEMBL_942634
Residue:
221
Sequence:
MPVMRLFPCFLQLLAGLALPAVPPQQWALSAGNGSSEVEVVPFQEVWGRSYCRALERLVDVVSEYPSEVEHMFSPSCVSLLRCTGCCGDENLHCVPVETANVTMQLLKIRSGDRPSYVELTFSQHVRCECRHSPGRQSPDMPGDFRADAPSFLPPRRSLPMLFRMEWGCALTGSQSAVWPSSPVPEEIPRMHPGRNGKKQQRKPLREKMKPERCGDAVPRR
  
Inhibitor
Name:
BDBM50339227
Synonyms:
(S)-4-((S)-1-((3S,6R,11R,14S,17S,20S,26S,31aS)-17-((1H-indol-3-yl)methyl)-14-(2-amino-2-oxoethyl)-6-((5S,8S,11S)-16-amino-5-carbamoyl-16-imino-8-isopropyl-7,10-dioxo-2-thia-6,9,15-triazahexadecan-11-ylcarbamoyl)-26-isobutyl-20-isopropyl-3-methyl-1,4,12,15,18,21,24,27-octaoxooctacosahydro-1H-pyrrolo[2,1-j][1,2,5,8,11,14,17,20,23,26]dithiaoctaazacyclononacosin-11-ylamino)-3-methyl-1-oxobutan-2-ylamino)-3-((S)-2-acetamido-3-phenylpropanamido)-4-oxobutanoic acid | CHEMBL1689453
Type:
Small organic molecule
Emp. Form.:
C78H117N21O19S3
Mol. Mass.:
1749.088
SMILES:
CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc2ccccc2)NC(C)=O)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N2CCC[C@H]2C(=O)N[C@@H](C)C(=O)N1)C(C)C)C(N)=O |r,wU:70.71,110.114,84.87,4.4,12.19,32.32,44.52,106.109,62.63,wD:95.98,8.8,36.40,23.22,28.28,(-3.76,-50.23,;-2.43,-49.45,;-2.43,-47.91,;-1.09,-47.14,;-1.09,-45.61,;.25,-44.83,;1.58,-45.61,;1.58,-47.14,;2.91,-44.83,;4.26,-45.61,;5.59,-44.83,;5.59,-43.29,;6.92,-45.61,;6.92,-47.14,;5.59,-47.91,;5.59,-49.45,;4.26,-50.23,;4.26,-51.77,;5.59,-52.54,;2.91,-52.54,;8.25,-44.84,;9.58,-45.61,;9.58,-47.14,;10.91,-44.83,;10.91,-43.3,;9.59,-42.48,;9.61,-40.91,;8.27,-40.11,;8.28,-38.55,;6.96,-37.79,;5.61,-38.53,;5.61,-40.07,;4.27,-37.78,;2.94,-38.55,;1.62,-37.79,;1.62,-36.26,;.27,-38.57,;.29,-40.1,;-1.05,-40.89,;-2.41,-40.13,;-1.03,-42.45,;-1.04,-37.8,;-1.03,-36.25,;.32,-35.48,;-2.37,-35.46,;-2.37,-33.9,;-1.01,-33.13,;.33,-33.92,;1.68,-33.15,;1.69,-31.6,;.34,-30.81,;-1.01,-31.58,;-3.73,-36.23,;-5.07,-35.45,;-6.42,-36.22,;-5.06,-33.89,;4.28,-36.25,;5.59,-35.47,;2.93,-35.48,;9.65,-37.79,;10.98,-38.53,;9.59,-36.31,;10.92,-35.53,;10.94,-34,;9.59,-33.22,;8.24,-33.98,;9.6,-31.66,;12.26,-36.32,;12.25,-37.86,;13.6,-35.57,;14.92,-36.36,;16.24,-35.61,;16.26,-34.07,;17.53,-33.2,;17.07,-31.73,;15.53,-31.71,;14.52,-30.56,;13.02,-30.86,;12.53,-32.32,;13.55,-33.46,;15.04,-33.16,;14.9,-37.89,;13.56,-38.65,;16.23,-38.67,;20.17,-36.4,;21.51,-35.63,;21.5,-34.1,;22.83,-36.4,;20.19,-37.95,;21.52,-38.71,;18.88,-38.7,;18.86,-40.25,;17.53,-41.03,;16.2,-40.28,;17.55,-42.57,;16.21,-43.35,;14.89,-42.58,;13.54,-43.36,;12.19,-42.58,;13.54,-44.92,;16.22,-44.88,;14.9,-45.65,;17.56,-45.63,;19.02,-45.16,;19.92,-46.41,;19.01,-47.65,;17.55,-47.17,;16.21,-47.93,;16.2,-49.47,;14.89,-47.16,;13.56,-47.91,;13.54,-49.46,;12.23,-47.15,;10.9,-47.91,;12.24,-45.61,;2.91,-43.27,;4.26,-42.49,;1.56,-42.5,;-2.43,-44.83,;-3.76,-45.61,;-2.43,-43.29,)|
Structure:
Search PDB for entries with ligand similarity: